Chad Cowan - 01 Oct 2024 Form 3 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Scientific Officer
Signature
/s/ Douglas Carr, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
01 Oct 2024
Net transactions value
$0
Form type
3
Filing time
03 Oct 2024, 18:04:06 UTC
Next filing
12 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IPSC Common Stock 136,430 01 Oct 2024 Direct
holding IPSC Common Stock 10,697 01 Oct 2024 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Cowan Investment Nominee Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

Remarks:

Exhibit 24 - Power of Attorney